Disposable Specimen Retrieval Bag Top Quality Factory Outlet-Huaren Pharmaceutical
| FOB Price: | US$6.00-20.00 / Piece |
|---|---|
| Min. Order: | 100 Pieces |
| Min. Order | FOB Price |
|---|---|
| 100 Pieces | US$6.00-20.00 |
| Port: | Qingdao, China |
|---|---|
| Production Capacity: | 10000000pieces/Year |
| Payment Terms: | L/C, T/T |
){kind=link}
Similar Items
Loading...
You May Like
Loading...
Product Description
Company Info
Address:
No. 187, Zhuzhou Road, High-Tech Industrial Park, Qingdao, Shandong, China
Business Type:
Manufacturer/Factory
Business Range:
Health & Medicine, Manufacturing & Processing Machinery
Management System Certification:
ISO 9001, GMP, ISO 13485
Main Products:
Pharmaceutical/Medical/Surgical Instruments
Company Introduction:
Founded in May 1998, Huaren Pharmaceutical is a modern pharmaceutical and health industry group integrating R&D, production and sales, focusing on medicine, APIs, medical devices and medical services.
After more than 20 years of development, the company′s business focuses on nephrology, respiratory, fine hemp and large-volume infusion and other fields, and has successively built five production bases in Qingdao, Rizhao, Xiaogan, Pubei and Hefei, with a total production capacity of 950 million bags (bottles), and all production lines have passed the new GMP certification.
The company′s main products include small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices, tablets, capsules, powders, granules, supporting drug packaging, health products and APIs, etc., with a total of104 varieties and 217 specifications of existing drugs, realizing the integrated development of "raw materials + infusion and injection + pharmaceutical packaging materials".
In the future, the company will actively respond to the national "Healthy China" strategy, take product strength construction as the support, actively promote the strategic layout of pharmaceutical health through synchronize independent research and collaborative innovation, and strive to grow into a pharmaceutical and health industry group integrating APIs, infusion and injection, medical devices, pharmaceutical packaging materials and other sectors with comprehensive and coordinated development.
After more than 20 years of development, the company′s business focuses on nephrology, respiratory, fine hemp and large-volume infusion and other fields, and has successively built five production bases in Qingdao, Rizhao, Xiaogan, Pubei and Hefei, with a total production capacity of 950 million bags (bottles), and all production lines have passed the new GMP certification.
The company′s main products include small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices, tablets, capsules, powders, granules, supporting drug packaging, health products and APIs, etc., with a total of104 varieties and 217 specifications of existing drugs, realizing the integrated development of "raw materials + infusion and injection + pharmaceutical packaging materials".
In the future, the company will actively respond to the national "Healthy China" strategy, take product strength construction as the support, actively promote the strategic layout of pharmaceutical health through synchronize independent research and collaborative innovation, and strive to grow into a pharmaceutical and health industry group integrating APIs, infusion and injection, medical devices, pharmaceutical packaging materials and other sectors with comprehensive and coordinated development.